Double-blind, Placebo-controlled study of BGC20-1531 in Migraine

• Research type

  Research Study

• Full title

  A multinational, multicentre, randomised, double-blind, placebo-controlled, 3-way crossover study in migraine patients, treated with two doses of BGC20-1531 and placebo

• IRAS ID

  20502

• Contact name

  E Anne MacGregor

• Contact email

  anne.macgregor@migraineclinic.org.uk

• Eudract number

  2009-010862-43

• ISRCTN Number

  N/A

• Research summary

  Research Summary not published at request of researcher

• REC name

  London - City & East Research Ethics Committee

• REC reference

  09/H0703/65

• Date of REC Opinion

  11 Jun 2009

• REC opinion

  Further Information Favourable Opinion